Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Electroacupuncture as a Treatment for Refractory Overactive Bladder

NCT: NCT07124390 · RECRUITING

NCT IDNCT07124390
StatusRECRUITING
Start Date2026-08-15
Completion2027-12-30
SponsorChelsea and Westminster NHS Foundation Trust (OTHER)
First posted
Last updated

Brief Summary

This study is a single-site feasibility randomised controlled trial evaluating the feasibility and acceptability of electroacupuncture (EA), and percutaneous tibial nerve stimulation (PTNS), in women with refractory overactive bladder (OAB) who have not achieved satisfactory improvement following standard pelvic health physiotherapy. The primary aim is to determine whether a larger definitive trial is feasible by assessing recruitment, consent, retention, treatment adherence, data completeness, intervention delivery, safety, and participant acceptability. Twenty-four participants will be randomly allocated to receive electroacupuncture or PTNS, over a 12-week treatment period. Outcome assessments will be completed at baseline, 6 weeks, 12 weeks, 6 months, and 12 months. The findings will inform the design of a future definitive randomised controlled trial and contribute to the evidence base for non-pharmacological treatment options for overactive bladder.

Frequently Asked Questions

What is Electroacupuncture as a Treatment for Refractory Overactive Bladder?

Electroacupuncture as a Treatment for Refractory Overactive Bladder is a clinical trial registered under NCT07124390. Current status: RECRUITING.

What is the status of NCT07124390?

The current status of NCT07124390 (Electroacupuncture as a Treatment for Refractory Overactive Bladder) is: RECRUITING.

When did Electroacupuncture as a Treatment for Refractory Overactive Bladder start?

Electroacupuncture as a Treatment for Refractory Overactive Bladder started on 2026-08-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑